Literature DB >> 25085340

Humanized anti-IFN-γ (HuZAF) in the treatment of psoriasis.

Jamie L Harden1, Leanne M Johnson-Huang1, Maria Francesca Chamian1, Edmund Lee1, Tillman Pearce2, Craig L Leonardi3, Asifa Haider1, Michelle A Lowes1, James G Krueger4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25085340     DOI: 10.1016/j.jaci.2014.05.046

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  31 in total

1.  Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.

Authors:  Mehdi Rashighi; John E Harris
Journal:  Ann Transl Med       Date:  2015-12

2.  Elucidating new drug targets in psoriasis by gene profiling: an opportunity to be seized.

Authors:  Mark R Walter
Journal:  Ann Transl Med       Date:  2015-04

3.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.

Authors:  Jo Ann LeQuang
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

Review 4.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

5.  Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis.

Authors:  M De Andrea; M De Santis; V Caneparo; E Generali; S Sirotti; N Isailovic; G M Guidelli; A Ceribelli; M Fabbroni; A Simpatico; L Cantarini; P Gisondi; L Idolazzi; M Gariglio; C Selmi
Journal:  Clin Exp Immunol       Date:  2019-10-15       Impact factor: 4.330

Review 6.  Immune responses and therapeutic options in psoriasis.

Authors:  Inna S Afonina; Elien Van Nuffel; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

Review 7.  The continuing evolution of targeted therapy for inflammatory skin disease.

Authors:  C Schlapbach; A A Navarini
Journal:  Semin Immunopathol       Date:  2015-09-30       Impact factor: 9.623

8.  Chemical and genetic control of IFNγ-induced MHCII expression.

Authors:  Ruud H Wijdeven; Marvin M van Luijn; Annet F Wierenga-Wolf; Jimmy J Akkermans; Peter J van den Elsen; Rogier Q Hintzen; Jacques Neefjes
Journal:  EMBO Rep       Date:  2018-07-18       Impact factor: 8.807

Review 9.  Psoriatic arthritis under the influence of IFNγ.

Authors:  Hui Dai; Iannis E Adamopoulos
Journal:  Clin Immunol       Date:  2020-06-20       Impact factor: 3.969

Review 10.  The immunogenetics of Psoriasis: A comprehensive review.

Authors:  Jamie L Harden; James G Krueger; Anne M Bowcock
Journal:  J Autoimmun       Date:  2015-07-26       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.